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Forecasting sex differences in mortality in high income nations: 




To address the question of whether sex differences in mortality will in the future rise, 
fall, or stay the same, this study uses relative smoking prevalence among males and 
females to forecast future changes in relative smoking-attributed mortality.  Data on 21 
high income nations from 1975 to 2000 and a lag between smoking prevalence and 
mortality allow forecasts up to 2020.  Averaged across nations, the results for logged 
male/female ratios in smoking mortality reveal equalization of the sex differential.   
However, continued divergence in non-smoking mortality rates would counter 
convergence in smoking mortality rates and lead to future increases in the female 
advantage overall, particularly in nations at late stages of the cigarette epidemic (such 
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1. Introduction  
The analysis of national differences in the relative mortality rates of men and women 
for smoking-attributed deaths and other deaths suggests that the small declines in the 
sex differential in mortality observed recently in high income nations stem from two 
counterbalancing trends:  Smoking-attributed deaths rose among women relative to 
men, while other deaths rose among men relative to women (Pampel 2002).  From 1975 
to 1995, the separate cause-specific trends produced little change overall in the total sex 
differential.  In addition, differences across nations in the rise of female smoking-
attributed deaths and the decline of the sex differential in smoking mortality rates is 
associated more closely with patterns of cigarette diffusion than gender equality 
(Pampel 2003).  Nations at advanced stages of cigarette diffusion, where women have 
had a longer time to catch-up with the earlier adoption of men, showed convergence in 
female and male smoking-attributed mortality, whereas nations at the early stages, 
where women have not adopted smoking in large numbers, showed divergence in 
female and male smoking-attributed mortality. 
This argument about the source of national differences views cigarette use and 
smoking mortality as a type of epidemic or diffusion process that rises slowly at first, 
accelerates to a peak, begins to abate, and falls to levels below the peak (Ferrence 1989; 
Lopez, Collishaw, and Piha 1994).  The pattern of change occurs among both men and 
women, but, because men adopt cigarettes in large numbers earlier than women, the 
male changes precede the female changes by a decade or two (Department of Health 
and Human Services (DHHS) 2001:135; Lopez 1995; Nathanson 1995; Pampel 2001).  
With men affected by the epidemic first, the sex differential initially grows.  Later, as 
smoking mortality among men peaks and begins rising among women, the differential 
stops growing.  Still later, as smoking mortality declines among men, it grows among 
women (just as it had earlier among men).  Therefore, the differential begins to narrow.  
The lag in the process for women means, in short, that the more advanced the stage of 
the epidemic (i.e., the earlier the diffusion process begins and the farther it proceeds), 
the closer the smoking mortality rates of men and women. 
This paper extends previous findings and further evaluates the cigarette diffusion 
argument in four ways.   
First, it updates mortality figures to 2000.  Section 1 describes the indirect 
estimation methods used to decompose mortality rates of males and females into 
smoking and non-smoking rates, the nations and years in the sample, the logged 
male/female mortality ratios used to measure the sex differential, and the other 
measures used in the models.   
Second, it more formally models the temporal and national patterns of the logged 
ratios with multivariate models.  Section 2 regresses relative levels of male and female Demographic Research: Volume 13, Article 18 
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smoking and non-smoking mortality on a measure of cigarette diffusion to show how 
the stage of the smoking epidemic affects national differences in the logged ratios.    
Third, it uses regression models to forecast changes in the logged ratios of 
smoking mortality.  Section 3 presents forecasts that rely on the relationship between 
relative smoking mortality rates and smoking prevalence for females and males several 
decades earlier.  The lag in the effect of smoking prevalence on mortality combined 
with knowledge of recent changes in relative smoking prevalence allow forecasts of 
relative smoking mortality rates in decades to come.   
Fourth, it uses the forecasts of logged ratios in smoking mortality and presumed 
changes in logged mortality ratios from non-smoking causes to predict logged mortality 
ratios from all causes.  Section 4 combines separate forecasts by cause to predict the 
expected change in the logged ratios for each nation and to demonstrate how the 
approach compares to simple projections. 
Such efforts remain preliminary but perhaps offer one means to help answer a 
puzzling question:  Will women’s advantage in mortality rise, stay unchanged, or fall 
over the next several decades? 
 
 
2. Estimating smoking-attributed mortality  
2.1 Harm of smoking  
The harm of cigarette use on male and female mortality emerges most clearly in the 
traditionally high rates of lung cancer mortality among men and the movement toward 
convergence between men and women in recent decades.  With around 90 percent of 
lung cancer deaths stemming from cigarette use (Thun et al. 1995), the trends in this 
form of death directly reflect trends in smoking.  However, identifying the full harm of 
cigarette use and the whole influence it has on the sex differential in mortality requires 
attention to causes of death other than lung cancer.  According to estimates of the U.S. 
Surgeon General (DHHS 1989), only 28 percent of tobacco-related deaths involve lung 
cancer.  The risks of lung cancer mortality among current smokers ages 35 and over 
relative to nonsmokers are 22.4 times higher for men and 11.9 times higher for women.  
In addition, the relative risks of mortality to smokers from bronchitis and emphysema 
are 9.7 (males 35+) and 10.5 (females 35+), from cerebrovascular disease are 3.7 
(males 35-69) and 4.8 (females 35-69), and from ischemic heart disease are 2.8 (males 
35-69) and 3.0 (females 35-69).  Similarly, in a 40-year study of British doctors (Doll et 
al. 1994), smoking raised the rate of death from lung cancer by a factor of 14.9, but also 
raised the rate of death from other cancers by 1.5, respiratory diseases by 2.9, ischemic 
heart disease by 1.6, and all causes combined by 1.8.   Pampel: Forecasting sex differences in mortality in high income nations  
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A full accounting of the harm of tobacco must include deaths from causes other 
than lung cancer, and an accurate estimate of the role of smoking for the sex differential 
in mortality should include male and female deaths from causes other than lung cancer.  
In one study of mortality in Denmark, Finland, Norway, Sweden, and the Netherlands, 
for example, Valkonen and van Poppel (1997) found that 40 percent of the total sex 
difference in life expectancy in 1970-1974 came from smoking.  Because of the decline 
in smoking-attributed mortality among men relative to women, the contribution 
dropped in 1985-1989 to about 30 percent of the total difference.  Such results confirm 
the importance to the sex differential in mortality of smoking-related deaths from 
causes other than lung cancer. 
 
 
2.2 Indirect estimates 
To calculate smoking-attributed mortality rates by age and sex, Peto et al. (1992, 1994) 
employ indirect estimation techniques.  The indirect estimates differ from other 
approaches to calculating smoking-attributed mortality (DHHS 1989; Brønnum-Hansen 
and Juel 2000; Valkonen and van Poppel 1997) in a crucial way:  Without direct 
measures of the prevalence of smoking for an extensive sample of nations, Peto et al. 
use excess lung cancer rates in a population to infer the cumulative exposure to 
cigarette smoking, and ultimately the proportion of deaths from other diseases due to 
smoking.  Based on the method, they report deaths for 1) males and females, 2) ages 0-
34, 35-69, and 70 and over, 3) smoking-attributed causes, other causes, and all causes, 
and 4) the years 1975, 1985, 1990, and 1995.  Updated figures for 2000 come from the 
Tobacco Control Country Profiles (World Health Organization 2004)
2.   
The appendix describes the estimation procedure and debate over its validity in 
more detail, but several strengths of the method deserve emphasis.  First, because lung 
cancer rates fall to low levels in the absence of smoking, the difference between the 
observed lung cancer rate and the lung cancer rate expected for a non-smoking 
population serves as an indicator of the cumulative exposure to smoking that can be 
obtained without reliable and consistent measures of cigarette use.  Such an approach 
may better reflect the extent of cigarette use than survey questions about smoking 
habits.  Self-reported cigarette use, although generally accurate at the time of a survey 
(DHHS 2001:151-152), may not capture key details about an individual’s lifetime 
exposure  – age of initiation, periods of cessation, cigarettes per day, tar levels of 
cigarettes, and degree of inhalation.  It also fails to capture the harm from passive 
                                                        
2 For some nations that reported data for 1997, 1998, or 1999, the 2000 figures are obtained by extrapolating to 2000 the trends from 1995 to the 
most recent year available. Demographic Research: Volume 13, Article 18 
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smoking.  Lung cancer mortality, in contrast, responds to each of these dose-based 
factors and does not involve the same kind of error as self-reported cigarette use.   
Second, the use of excess lung cancer mortality to estimate smoking-attributed 
mortality allows for meaningful forecasts.  The Centers for Disease Control (2004) use 
current smoking prevalence as a component of estimates of smoking-attributed 
mortality in the United States, although the harm from cigarette use typically builds for 
several decades before causing death.  In contrast, excess lung cancer mortality reflects 
smoking prevalence over previous decades and better captures the lag in the harm of 
smoking.  Given that past smoking determines (albeit imperfectly) current excess lung 
cancer mortality and smoking-attributed mortality
3 then current smoking can be used to 
forecast future smoking mortality.  Use of current smoking prevalence to estimate 
current smoking-attributed mortality does not have this advantage.  
Third, the estimates of smoking-attributed mortality appear most accurate at 35-69, 
ages with special significance for premature smoking mortality.  For ages 0-34, the 
estimates assume that no deaths occur from tobacco, which likely understates the harm 
to children and young people from early smoking onset and the smoking of parents.  
Such harm nonetheless remains small relative to that at older ages.  For ages 70 and 
over, problems in isolating specific causes of death make the indirect estimates of 
smoking-attributed mortality less reliable than at younger ages.  Moreover, because 
those who die of smoking causes after age 70 would likely soon die from non-smoking 
causes, smoking mortality at these ages contributes little to reducing life expectancy.  
Yet, the estimates at ages 35-69 prove more useful:  They are more reliable, better 
reflect premature mortality from smoking, and contribute more to lowering life 
expectancy than estimates at younger and older ages.
4   
Fourth, any estimation procedure faces daunting problems in correctly determining 
the number or rate of smoking-attributed deaths and the Peto et al. method has been 
criticized on several grounds.  The method also faces difficulties common to all 
mortality research, such as dealing with the existence of differences across nations and 
over time in coding causes of death.  However, the absolute level or rate of smoking 
deaths has little importance for study of the sex differential, which is based on smoking 
and non-smoking deaths of women relative to men.  If the percentage error in the 
indirect estimates is similar for men and women, it will cancel out in measures of the 
differential.  Even should the error differ for men and women and bias comparisons 
across nations and time, the extent of the problem will be considerably smaller than that 
for estimates of the absolute levels of smoking-attributed deaths.  
                                                        
3 Because cessation of smoking can bring rapid benefits for heart disease, declining rates of cigarette use can have short-term benefits for 
mortality.  Still, long-term harm of smoking at younger ages for mortality at older age make lags for cigarette use appropriate. 
4 Although reported in three age groups, the estimates are based on data for five-year age groups and thus standardize for age structure differences 
across nations and time. Pampel: Forecasting sex differences in mortality in high income nations  
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2.3 Nations and measures   
I select for analysis the 21 high income, capitalist nations with populations over one 
million.  These nations include the United States, Canada, Japan, Australia, New 
Zealand, and those of Western Europe (Finland, Sweden, Norway, Denmark, the United 
Kingdom, Ireland, Germany, the Netherlands, Belgium, France, Austria, Switzerland, 
Spain, Portugal, Italy, and Greece).  The high income nations comprise an appropriate 
sample because, unlike developing nations, they have recently experienced both the 
widening and the narrowing of the sex differential, once exhibited high tobacco use, 
and, with lower mortality overall, have experienced substantial harm of tobacco for 
premature mortality.  
Logged ratios of male to female mortality serve as measures of the sex 
differentials in mortality.  With male rates in the numerator and female rates in the 
denominator, high scores indicate excess male mortality and a female advantage.  A 
common measure of the sex differential divides one rate by the other without the log 
transformation.  However, changing the denominator changes the implicit standard of 
comparison, can alter the scale of the ratio values, and makes results dependent on an 
arbitrary choice.  This becomes a special problem when the denominator approaches 
zero (such as the smoking-attributed mortality rate for women where female cigarette 
use has only recently begun) and the ratio becomes exceedingly large.  Taking the log 
of the ratio, in contrast, eliminates the influence of choosing one denominator over the 
other; the log of the ratio of female rates to male rates gives the inverse of the log of the 
ratio of male rates to female rates.  It also moderates extreme values due to near zero 
denominators and can be interpreted as the difference in the logged rates of female and 
male mortality.
5   
In what follows, then, the logged total mortality ratio, logged smoking mortality 
ratio, and logged non-smoking mortality ratio refer to relative male and female rates of, 
respectively, mortality overall, smoking-attributed mortality, and other mortality.   
Three other measures are used in the analyses.  First, a measure of the stage of 
cigarette diffusion relies on historical figures on cigarette consumption from Forey et al. 
(2002).  Focusing on a nation’s movement through the process of cigarette diffusion, 
the measure identifies the timing of the start of the epidemic.  The earlier the cigarette 
diffusion process begins, the later or more advanced the current stage; conversely, the 
later the process begins, the earlier or less advanced the current stage.  Specifically, a 
measure of the decades since cigarette consumption reached 50 percent of its eventual 
                                                        
5 For example, a few nations in the early years have no female smoking-attributed deaths and a small constant (.01) is added to avoid dividing by 
zero.  As a result, the maximum value of the ratio of male smoking mortality to female smoking mortality is 2371.83 and the mean is 62.45.  The 
logged ratio adjusts the skew downward.  The same advantage of reducing skew comes in comparison to methods that would subtract one rate 
from the other.  The logged ratio focuses on percentage changes or change in mortality rates relative to starting points. Demographic Research: Volume 13, Article 18 
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peak distinguishes nations that long ago began the epidemic and have reached a more 
advanced stage of the diffusion process from nations that began more recently and have 
advanced less far in the cigarette diffusion process.
6  
Second, measures of the percentages of adult men and women who smoke are 
available every five years from 1950 to 1995 for most nations (Forey et al. 2002).
7 As 
determinants of smoking mortality, the percentage prevalence measures among men 
and women have limitations.  They do not distinguish the intensity or history of 
cigarette use in a population, can be biased by use of different types of survey questions 
and samples, and sometimes show unexpected and large fluctuations.  Despite these 
limitations, however, the validity and reliability of the logged ratio of male prevalence 
to female prevalence is demonstrated in the analyses by the strong relationship it has 
with the logged ratio of smoking mortality. 
Third, overall cigarette consumption (without regard to sex differences) helps 
determine the importance of smoking mortality to total mortality.  Based on figures 
from Forey et al. (2002), I measure the packages of 20 cigarettes smoked per person per 
year from 1950 to 1995 for each nation.   
 
 
3. Trends and national differences 
3.1 Trends   
The first step in the analysis examines the trends in male mortality rates, female 
mortality rates, and the logged ratio of male to female mortality rates by age and cause 
of death.  The age groups include 0-34, 35-69, 70+, and all ages.  The figures for all 
ages come from a weighted average of the values for the three age groups, with the 
weights equal to the mean population size averaged across all nations and years.
8  The 
causes of death include smoking-attributed, non-smoking attributed, and all causes or 
total.  Table 1 lists the means averaged across all 21 nations for 1975 and 2000, and the 
proportional increase from 1975 to 2000.   
The mean male and female mortality rates decline for all ages and all causes with a 
few exceptions.  The exceptions involve rising smoking mortality rates among women 
ages 35 and over.  In contributing to total mortality, these increases in female smoking 
mortality moderate the decline in mortality from other causes.  In combination with the 
                                                        
6 Even nations at earlier stages of cigarette diffusion such as Spain and Portugal experienced a peak in cigarette use by the 1990s – although one at 
lower levels than nations at later stages. 
7 To obtain a complete time series for some nations that did not begin reporting the figures until after 1950, I estimated values for earlier years on 
the basis of trends in later years. 
8 The mean proportion of the population at ages 0-34 equals .502, at ages 35-69 equals .408, and at 70 and over equals .091. Pampel: Forecasting sex differences in mortality in high income nations  
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decline in male smoking mortality, the rise in female smoking mortality will equalize 
the sex differential.  
 
 
Table 1:  Mean Mortality Rates per 1,000 for Males and Females,  
  and Logged Ratios by Year, Age, and Cause of Death,  
  High Income Nations 1975-2000 (N = 21) 
 
Age and Cause  Male  Female  Logged Ratio 
 1975  2000  ∆
a 1975  2000  ∆
a 1975 2000  ∆
a 
Ages  0-35                
   Total  1.48  .77  -.47  .85  .39  -.54  .56  .69  .24 
Ages  35-69                
   Smoking  3.39  1.68  -.50  .38  .51  .32  2.93  1.48  -.50 
   Non-Smoking  8.03  4.83  -.40  5.73  3.05  -.47  .33  .46  .37 
   Total  11.42  6.51  -.43  6.11  3.56  -.42  .62  .60  -.03 
Ages  70+                
   Smoking  16.06  13.28  -.17  1.41  4.60  .03  3.66  1.62  -.56 
   Non-Smoking  75.76  57.26  -.24  66.72  52.39  -.21  .13  .09  -.29 
   Total  91.82  70.54  -.23  68.13  51.96  -.16  .30  .22  -.27 
All  Ages                
   Smoking  2.84  1.89  -.33  .29  .63  .01  1.52  .75  -.51 
   Non-Smoking  10.90  7.56  -.31  8.83  6.20  -.30  .43  .54  .27 
   Total  13.74  9.45  -.31  9.11  6.83  -.25  .56  .61  .09 
 
a Proportional change from 1975 to 2000 
 
 
Focusing on trends in the logged ratios, the key elements of the pattern of change 
appear in the means at ages 35-69:  Male excess mortality or the female advantage rises 
significantly for the logged ratio of non-smoking mortality rates, falls significantly for 
the logged ratio of the smoking mortality rates, and, given the opposite trends for the 
components, changes little for the logged ratio of total mortality.
9  The logged ratio for 
smoking deaths falls by 50 percent and for non-smoking deaths rises by 37 percent.  
The two trends nearly counterbalance one another, but with non-smoking deaths 
comprising a higher proportion of the total, the logged ratio for all mortality falls 
slightly – by 3 percent.   
                                                        
9 Note that the mean logged ratios reported in the last columns of the table do not equal calculations based on the means reported in the previous 
columns.  Taking the logged ratio after calculating the means for males and females is algebraically not equivalent to taking the logged ratio of 
each individual case and then calculating the mean.  The logged ratios in Table 1 equal the latter rather than the former. Demographic Research: Volume 13, Article 18 
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The source of this change stems from the increase in smoking mortality rates 
among females and a decrease among males.  To illustrate, 29.2 percent of men and 5.8 
percent of women died from smoking-related causes in 1975, while the percentage fell 
to 25.6 percent for men and rose to 13.6 percent for women in 2000.  Hence, the logged 
smoking mortality ratio falls steeply over the 25-year span.  For non-smoking mortality, 
rates fall faster for women than men and produce an increase in the logged non-
smoking mortality ratio.   
Much as it does for the middle age group, the logged non-smoking mortality ratio 
or female advantage for the ages 0-35 rises by 24 percent (smoking deaths equal zero in 
all years).  However, the pattern differs at the oldest ages, where both the logged non-
smoking mortality ratio and the logged smoking mortality ratio decline.  For all ages 
combined, the trends largely reflect those at the younger ages.  The logged smoking 
mortality ratio falls (i.e., women’s relative mortality worsens), the logged non-smoking 
mortality ratio rises (i.e., women’s relative mortality improves), and the logged total 
mortality ratio changes little. 
 
 
3.2 National differences  
These patterns of change differ strikingly across nations.  If rates of smoking and total 
mortality of women relative to men depend on the stage of cigarette diffusion, the 
simple measure of the decades since the halfway point to the peak may identify crucial 
heterogeneity across nations.  The regression results to follow thus demonstrate two 
points.  First, nations at more advanced stages, where smoking of women has had time 
to catch up with smoking of men, experience greater equality in male and female 
smoking mortality rates.  Second, and perhaps less obviously, nations at more advanced 
stages of diffusion experience a weaker upward trend in the female advantage overall 
because of the greater equality in male and female smoking mortality rates.  
Table 2 lists coefficients for regressions of the logged ratios on year, the cigarette 
diffusion measure, and the product of year times cigarette diffusion
10  The regression 
uses the cigarette diffusion measure after centering it to have a mean of zero, and year 
equals zero for 1975.  The constant therefore equals the predicted logged ratio in 1975 
at the mean of cigarette diffusion, the effect of year equals the yearly change in the 
predicted logged ratio at the mean of cigarette diffusion, the effect of cigarette diffusion 
equals the change in the predicted logged ratio for a decade change in diffusion (in 
1975 when year equals zero), and the product term shows how the yearly change differs 
                                                        
10 As alternatives to ordinary least squares, other regression estimates that adjust for the nested structure of the pooled cross-section and time-
series data by allowing the error to be correlated within nations and to have variances that differ across nations change the results only slightly. Pampel: Forecasting sex differences in mortality in high income nations  
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by level of cigarette diffusion.  Consistent with arguments about cigarette diffusion, a 
negative product term would indicate that a later stage of diffusion moderates the 
upward trend in the logged ratios.   
For the logged non-smoking mortality ratio, cigarette diffusion and its interaction 
have (as would be expected) no effects for any of the three age groups.  Consistent with 
the changes in means presented in Table 1, the year term in the regression is positive for 
the two younger age groups but insignificant at the older ages.  For the logged smoking 
mortality ratio, the negative year coefficients reflect the downward trend, and those 
nations at later stages of diffusion have lower logged smoking mortality ratios on 
average than those nations at earlier stages.  The cigarette diffusion measure thus 
equalizes male and female death rates.   
 
 
Table 2:  Unstandardized Coefficients for OLS Regression of Logged Mortality 
  Ratios on Year, Cigarette Diffusion, and Interaction, High Income  
  Nations 1975-2000 (N = 105, 21 nations, 5 years) 
 




Cig. Diff.  R
2 
Ages 0-35           
   Total  .577  .065**  .003  -.003  .200 
Ages 35-69           
   Smoking  2.912  -.548**  -.098**  -.009  .426 
   Non-Smoking  .329  .050**  .000  -.000  .145 
   Total  .637  -.006  .001  -.006**  .238 
Ages 70+           
   Smoking  3.523  -.782**  -.089*  -.023  .334 
   Non-Smoking  .136  -.010  .002  -.000  .056 
   Total  .320  -.028**  .005**  -.003**  .226 
All Ages           
   Smoking  1.507  -.294**  -.048**  -.006  .416 
   Non-Smoking  .436  .052**  .002  -.002  .250 
   Total  .578  .028**  .002  -.004**  .195 
 
* p < .05   ** p < .01 
 Demographic Research: Volume 13, Article 18 
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More interestingly, the interaction terms indicate that the time trend becomes more 
negative for nations at more advanced stages of diffusion.  This effect shows in the 
significant negative coefficients for year by cigarette diffusion on the logged total 
mortality ratio for both the older age groups and for all ages combined.  This implies 
that the differential narrows for nations at advanced stages and widens for nations at 
early stages.  For example, among nations at the early stages such as Spain or Greece, 
the effect of year for ages 35-69 equals .053 and reflects a worsening trend in smoking 
mortality among men relative to women.  In contrast, among nations at the late stages 
such as the United Kingdom or the United States, the effect of year equals -.127 and 
reflects a worsening trend in smoking mortality among women relative to men.  The 
trend in the logged mortality rates for all causes, in short, reverses with diffusion. 
 
 
4. Forecasting logged smoking and non-smoking mortality ratios  
4.1 Smoking mortality  
Something besides national differences in the timing of cigarette diffusion and a year 
term – merely proxies for unmeasured causes – is needed to account for variation in the 
logged smoking mortality ratios.  A measure of male smoking prevalence relative to 
female prevalence 25 years earlier should serve this purpose.  Since the harm of tobacco 
builds over decades of use, smoking prevalence many years earlier should more 
strongly affect smoking mortality than current prevalence and will allow for forecasts of 
smoking mortality into the future.  The logged ratio of male smoking prevalence to 
female smoking prevalence lagged 25 years thus has a correlation with the logged 
smoking mortality ratio at ages 35-69 of .740, which is larger than the contemporaneous 
correlation of .561 or any of the correlations for shorter lags.  Because the measure does 
not capture differences in intensity, initiation age, and recent cessation of smoking or 
differences in susceptibility to various smoking-related causes of death, the coefficient 
effect falls well below one.  Still, the strong relationship for the 25-year lag suggests the 
usefulness of using smoking prevalence to project future patterns of relative smoking 
mortality.   
Regression results further demonstrate the substantial influence of the logged 
smoking prevalence ratio on the logged smoking mortality ratio.  Table 3 first lists 
equations for ages over 35 (where smoking mortality is nonzero) that treat the logged 
and lagged smoking prevalence ratio as the central determinant of the logged smoking 
mortality ratio.  The two equations for each age group use and do not use fixed effects 
for nation dummy variables that control for national differences in the timing of 
cigarette diffusion and other stable factors that influence the logged smoking mortality Pampel: Forecasting sex differences in mortality in high income nations  
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ratio
11. For ages 35-69, the standardized coefficients equal .740 and .823 in the two 
equations.  For ages 70+, the standardized coefficients equal .564 and .765.  When 
including nation dummy variables, the variance explained reaches .875 for the middle 
ages and .786 for the older ages.  The equations for all ages combined average these 
effects and likewise show the strong influence of smoking prevalence on the logged 
smoking mortality ratio. 
 
 
Table 3:  Coefficients for OLS Regression Models of the Logged Smoking  
  and Non-Smoking Mortality Ratios, by Age, High Income Nations  
  1975-2000 (N = 105, 21 nations, 5 years) 
 
  Ages 0-34  Ages 35-69  Ages 70+  All Ages 
Coeff-  Fixed  Effects Fixed  Effects Fixed  Effects Fixed  Effects 
icients  No Yes No Yes  No Yes  No Yes 
Smoking Prevalence Lagged on the Logged Smoking Mortality Ratio 
b    --  --  1.693** 1.882** 1.752** 2.380**  .849**  .984** 
se  --  --  .152 .244 .253 .434 .083 .133 
beta  --  --  .740 .823 .564 .765 .711 .823 
R
2  --  --  .548 .875 .318 .786 .505 .864 
∆
a  --  --  -.336 -.373 -.307 -.416 -.330 -.382 
Year on the Logged Non-Smoking Mortality Ratio 
b    .065** .065** .050** .050**  -.010  -.010*  .052** .052** 
se  .014 .012 .012 .005 .008 .005 .009 .006 
beta  .420 .420 .379 .379  -.113  -.113 .488 .488 
R
2  .176 .500 .144 .866 .013 .762 .238 .756 
Alternate Predicted Proportional Change in Logged Non-Smoking Mortality Ratio  
∆
b  .176 .176 .221 .221  -.171  -.171 .185 .185 
∆
c   .088 .088 .111 .111  -.086  -.086 .092 .092 
∆
d  .000 .000 .000 .000 .000 .000 .000 .000 
∆
e  -.088 -.088 -.111 -.111  .086  .086 -.092 -.092 
 
* p < .05   ** p < .01 
∆ Predicted proportional change from 2000 to 2020 
a Based on smoking prevalence; 
b based on assumed linear rate of increase (or decrease at ages 70+); 
c based on assumed falling 
rate of increase (or decrease at ages 70+); 
d based on assumed no change; 
e based on assumed falling rate of decrease (or 
increase at ages 70+) 
                                                        
11 The models assume that the effect of smoking prevalence on smoking mortality is the same for all nations.  Efforts to allow the effects of 
smoking prevalence to vary across each nation did little to increase the explanatory power of the model and introduced considerable randomness 
to the predictions.  Other estimates that adjust for correlated errors and heteroscedasticity give essentially the same results. Demographic Research: Volume 13, Article 18 
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Calculating the predicted proportional change in the logged smoking mortality 
ratio from 2000 to 2020 demonstrates equalization of male and female smoking 
mortality rates.  With the logged prevalence ratio lagged 25 years and available up to 
1995, the model can forecast expected changes in the logged ratio to 2020.  As listed 
below the equations in Table 3, the models predict declines in the logged smoking 
mortality ratio ranging from 30.7 to 41.6 percent.  Figure 1 graphs the logged smoking 
mortality ratios for ages 35 and over as predicted by the fixed effects models and 
averaged across all nations.  Following the trend in lagged smoking prevalence, each 
curve declines over the period from 2000 to 2020.  Compared to past trends, however, 
the future trends reveal a slowing rate of decline.   
 
Figure  1: Predicted Trends (From Fixed Effects OLS Regression Models)   











































4.2 Other mortality  
Along with smoking mortality, the models must also consider non-smoking mortality 
because it contributes importantly to the sex differential overall.  For the logged non-
smoking mortality ratio, I avoid attempting to model substantive determinants.  Table 3 
uses a linear year term, again without and with dummy variable controls for nation, to Pampel: Forecasting sex differences in mortality in high income nations  
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determine and forecast the logged non-smoking mortality ratio for each age group.  At 
ages below 70, year increases the dependent variable, while year has only a small 
negative effect at ages over 70.  Based on the linear year terms and assuming that past 
trends continue into the future, the predicted logged non-smoking mortality ratio rises 
by 17.6 percent at ages 0-34, by 22.1 percent at ages 35-69, and by 18.5 percent over all 
ages, while the predicted ratio declines by 17.1 percent at ages 70 and over.   
The future trends may, however, differ from those of the recent past.  Indeed, the 
most recent year of observed data, 2000, reflects a slowing of the upward trend for ages 
0-34 and a decrease in the flat trend for ages 70 and over.
12  Figure 2, which graphs the 
observed trends for the four age groups, illustrates these changes from 1995 to 2000.  It 
is too early to know if the most recent changes reflect a long-term pattern, short-term 
fluctuation, or methodological oddity.
13  However, no slowdown appears in the linear 
upward trend for ages 35-69.  
To model possible changes in past trends, I specify three alternate trajectories in 
the logged non-smoking mortality ratio for the years after 2000.  Compared to the 
largely linear increase from 1975-2000 at ages below 70, the trends from 2000 to 2020 
may 1) continue to increase, but at a slower rate than in the past, 2) stop growing 
altogether and remain constant, or 3) start to decrease at a slower rate than the previous 
increase.  Examining the alternative trajectories can help determine how variation from 
the linear forecast influences total mortality.  For ages 70 and over, the weak downward 
trend from 1975 to 2000 may from 2000 to 2020 1) continue to decrease but at a slower 
rate than in the past, 2) stop decreasing altogether and remain constant, or 3) start to 
increase at a slower rate than the previous decrease.  Transforming the year term to 
reflect the three alternative trajectories and using each in a regression model produces 
predicted values for the logged non-smoking mortality ratio for the next 20 years. 
14 
The changes in the logged non-smoking mortality ratio implied by the alternatives 
vary widely.  The last panel in Table 3 lists the proportional change from 2000 to 2020.  
Whereas the continuation of the linear trends implies changes in the female advantage 
of 22.1 percent at ages 35-64, the alternatives imply percentage change ranging from 
11.1 to -11.1.  Whereas the continuation of the linear trends implies changes in the 
female advantage of -17.1 percent at ages 70 and over, the alternatives imply 
                                                        
12 Regression tests indicate that the flattening of the trend in 2000 at younger and older ages is not large enough to produce a significant deviation 
from linearity.  However, even a small and statistically insignificant change can prove important in years to come and could define a future 
trajectory that differs from the past. 
13 Two possible methodological sources might account for the change.  One, the 2000 figures come from a different source than the figures from 
1975-1995.  Although the 2000 figures use the same estimation method as earlier, some inconsistencies might have emerged.  Two, the 1995 
figures are actually based on projections and may exaggerate the extent of change occurring between 1995 and 2000. 
14 With the linear year term based on the actual years of 2005, 2010, 2015, and 2020, the year term reflecting a non-linear decreasing rate of 
growth takes values of 2004, 2007, 2009, and 2010.  The year term reflecting no change assigns all years the value of 2000.  And the year term 
reflecting a change in direction in the trend takes values of 1996, 1993, 1991, and 1990. Demographic Research: Volume 13, Article 18 
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percentage change ranging from -8.6 to 8.6.  Figure 3 illustrates how the alternatives 
vary from the linear trend for ages 35-69. 
 
Figure 2:  Observed Trends in Logged Non-Smoking Mortality Ratio  
















































Figure 3:  Alternate Predicted Trends in Logged Non-Smoking Mortality Ratio  
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5. Forecasting logged total mortality ratios   
5.1 Combining smoking and non-smoking forecasts 
The predicted logged smoking and logged non-smoking mortality ratios provide a 
means to forecast the logged ratios for all causes.  However, the forecast involves more 
than summation of the two components.  Although the smoking and non-smoking 
mortality rates sum to the total mortality rates, the component logged ratios do not sum 
in any simple way to produce the total logged ratio.  Instead, the observed logged total 
mortality ratio from 1975-2000 can be regressed on the predicted logged smoking and 
non-smoking ratios.  Then, the predicted values of the independent variables from 
2005-2020 plus the coefficients for the 1975-2000 model can generate predicted logged 
total mortality ratios for 2005-2020.
15 
However, the relative influence of the logged smoking and non-smoking ratios 
likely changes over time with patterns of cigarette use.  A regression that averages past 
values of the dependent and independent variables may have little validity in the future.  
Therefore, the model adds one other variable – cigarette consumption per person lagged 
25 years.  This measure does not distinguish male from female smoking.  Rather, it 
reflects the relative importance of smoking overall to mortality and thereby the size of 
the logged smoking coefficient relative to the logged non-smoking coefficient.  When 
allowed to interact with the logged smoking mortality ratio, cigarette consumption (25 
years earlier) modifies the contribution of the logged smoking mortality ratio to the 
logged total mortality ratio.
16  For example, when lagged consumption is low, the effect 
of the logged smoking mortality ratio should be small, and when lagged consumption is 
high, the effect of the logged smoking mortality ratio should increase.  In short, if 
cigarette consumption facilitates the effect of the logged smoking mortality ratio, a 
product term should have a positive coefficient.  
Table 4 presents the models of the logged total mortality ratio.  Based on earlier 
results, one model uses predicted values for the logged smoking and non-smoking ratios 
obtained without dummy nation variables and another model uses predicted values for 
                                                        
15 An alternative approach to forecasting takes advantage of the fact that the weighted sum of the unlogged smoking and non-smoking ratios 
equals the unlogged total mortality ratio when the weights equal the proportion of female smoking deaths and the proportion of female non-
smoking deaths.  The approach 1) takes the anti-log of the logged smoking and non-smoking mortality ratios predicted for the years 2005-2020, 2) 
forecasts the proportion female smoking deaths using cigarette consumption lagged, 3) computes the predicted unlogged total mortality ratio from 
the summation formula, and 4) calculates the log of the outcome to obtain predicted logged total mortality ratios.  This procedure has the 
advantage of using an exact formula to obtain the predicted logged mortality ratios rather than an estimated regression equation.  However, 
comparison of the two approaches shows that the regression approach does better to reproduce observed logged mortality ratios from the predicted 
smoking and non-smoking mortality ratios for the years up to and through 2000.  Because the exact formula directly reflects fluctuation and error 
in the predicted smoking and non-smoking mortality ratios, it deviates substantially in some cases from the observed values.  The regression 
approach smoothes these fluctuations and on average gives predicted values closer to the observed values.  In substantive terms, the results using 
the alternative approach are similar to those reported here but also likely not as accurate. 
16 With the component variables centered, the coefficient for the logged smoking mortality ratio alone equals its effect at the mean of cigarette 
consumption, and the coefficient of cigarette consumption alone equals its effect at the mean of the logged smoking mortality ratio. Demographic Research: Volume 13, Article 18 
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the logged smoking and non-smoking ratios obtained with dummy nation variables.  
Note that the predicted logged non-smoking mortality ratio is based on the continuation 
of the linear trend.  For ages 0-34, the models include only the predicted logged non-
smoking mortality ratio – a variable identical to the logged total mortality ratio because 
smoking deaths are zero.  For ages 35-69, the predicted logged non-smoking mortality 
ratio raises the logged total mortality ratio, while for ages 70 and over it lowers the 
logged total mortality ratio.  
The results confirm the expectation that the predicted logged ratio for smoking 
mortality has the strongest effect when lagged cigarette consumption reaches high 
levels.  The predicted logged ratio on average raises the logged total mortality ratio, but 
in addition, the product terms have significant positive coefficients.  Based on the fixed 
effects model for ages 35-69, the average effect of the predicted logged smoking 
mortality ratio of .097 increases by about a third (.036) for each additional package of 
20 cigarettes smoked per person per year in a nation or time period. 
The implications of the model show most clearly in the predicted trajectory of the 
logged total mortality ratio (listed in the bottom panel of Table 4).  Based on the 
assumed continuation of the linear trend in the logged non-smoking mortality ratio, the 
logged total mortality ratio rises by 17.6 percent at ages 0-34.  At ages 35-69, the 
change varies depending on the use of fixed effects and ranges from a 4.7 increase to a 
0.6 decrease.  The modest changes reflect near balance between the upward trend in the 
logged non-smoking mortality ratio and the downward trend in the logged smoking 
mortality ratio.  At the older ages, the decline in both the predicted logged smoking and 
non-smoking ratios from 2000 to 2020 contribute to declines of 32.9 or 8.3 percent in 
the logged total mortality ratio.   
Averaged across all ages and nations in the sample, the assumption of a linear 
continuation in the logged non-smoking ratios combined with the changes in the logged 
smoking ratios leads to a key forecast:  The logged ratios for mortality averaged across 
all 21 nations over the period from 2000 to 2020 will grow.  The specific percentages 
implied by the models equal 13.7 and 8.1 percent.  The rising ratio at the youngest ages 
overcomes the declining ratio due to smoking at older ages to produce the continued 
upward trend overall. 
However, projections based on alternate trajectories of the logged non-smoking 
mortality ratio suggest smaller future increases.  If the logged non-smoking mortality 
ratio is assumed to increase at a decreasing rate, the overall forecasts suggest increases 
in the logged total mortality ratio of 7.1 and 2.4 percent.  If the logged non-smoking 
mortality ratio remains at current levels, the predicted percentage change would remain 
constant.  Only if the logged non-smoking mortality ratio reverses direction to start 
declining at ages less than 70 would the forecasts become negative.  In this case, the 
logged total mortality ratio would fall by 6.0 or 8.9 percent.   Pampel: Forecasting sex differences in mortality in high income nations  
472   http://www.demographic-research.org 
Table  4:  Coefficients for OLS Regression Models of the Logged Total 
  Mortality Ratio, by Age, High Income Nations 1975-2000  
  (N = 105, 21 nations, 5 years)  
 
 0-34  35-69 70+  All  Ages 
Coeff-  Fixed  Effects 
a Fixed  Effects 
a Fixed  Effects 
a Fixed  Effects 
a 
icients  No Yes No Yes No Yes No Yes 
Predicted Logged Non-Smoking Mortality Ratio 
b  1.000**  1.000** .383  .368**  4.128** .525** .802** .697** 
se  .213 .099 .244 .064 .721 .099 .203 .074 
beta  .420 .707 .132 .311 .530 .520 .374 .580 
Predicted Logged Smoking Mortality Ratio 
b  --  --  .084**  .097** .011 .024**  .087**  .100** 
se  --  --  .011 .007 .006 .005 .019 .012 
beta  --  --  .702  1.020 .190 .625 .474 .711 
Lagged Cigarette Consumption  
b  --  --  -.004  .018* .016** .009  .040 .059** 
se  --  --  .011 .007 .006 .006 .021 .011 
beta  --  --  -.031 .162 .272 .162 .465 .692 
Predicted Logged Smoking Mortality Ratio x Lagged Cigarette Consumption 
b  --  --  .030** .036** .023** .016** .043** .050** 
se  --  --  .009 .005 .005 .003 .016 .009 
beta  --  --  .261 .436 .410 .536 .580 .593 
Const  .000 .000 .495 .480  -.213 .217 .314 .356 
R
2  .176 .500 .444 .720 .324 .285 .291 .630 
Predicted Proportional Change from 2000 to 2020 
∆
b   .176  .176  .047 -.006 -.329 -.083  .137  .081 
∆
c   .088  .088  .015 -.036 -.169 -.065  .071  .024 
∆
d   .000  .000 -.017 -.066 -.009 -.046  .006 -.032 
∆
e   -.088 -.088 -.048 -.096  .152 -.028 -.060 -.089 
 
* p < .05   ** p < .01 
a Based on predicted values from OLS regression of logged smoking and non-smoking ratios from models without and with fixed 
effects in Table 4 
b Based on assumed linear rate of increase (or decrease at ages 70+) in the logged ratio of nonsmoking mortality; 
c based on 
assumed falling rate of increase (or decrease at ages 70+); 
d based on assumed no change; 
e based on assumed falling rate of 
decrease (or increase at ages 70+)  
 
 
What contribution do relative rates of smoking mortality for men and women make 
to these projections?  In general, the predicted logged smoking mortality ratio 
moderates the assumed trend in the logged non-smoking mortality ratio.  For example, Demographic Research: Volume 13, Article 18 
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absent the influence of smoking, continuation of the linear trend in the logged non-
smoking mortality ratio for all ages implies an increase of 18.5 percent (see Table 3).  
However, adjusting for the trend in the logged smoking mortality ratio lowers the 
implied increase in the logged total mortality ratio to 13.7 and 8.1 (Table 4).   
 
 
5.2 National differences   
The results based on averages across 21 nations hide variation in the forecasts.  Indeed, 
if the stage of cigarette diffusion proves critical for past trends, then nations at different 
stages should exhibit different future trajectories.  To examine such heterogeneity, 
Table 5 lists the predicted proportional change in the logged total mortality ratio for 
each nation in the sample.  The predictions assume the logged non-smoking mortality 
ratio at ages under 70 will continue to increase but at a slower rate than in the past, and 
at ages over 70 will continue to decrease but at a slower rate than in the past.  The table 
orders the countries by the measure of cigarette diffusion stage (i.e., the decades since 
reaching the halfway point to the peak of cigarette consumption).  The predicted 
proportional changes by age come from both the basic and fixed effects models. 
For ages 0-34, smoking deaths equal zero, and the predicted trends merely reflect 
the continuation of positive growth, albeit at a slower rate, of the logged non-smoking 
mortality ratio in past decades.  The assumption of leveling off in past trends implies an 
average increase of 8.8 percent across all nations.  With adjustment for nation-specific 
differences, the assumed trend implies increases that range from 7.4 percent for Finland 
to 11.7 percent for the Netherlands.  By themselves, the patterns offer little in the way 
of insight and have little relationship to the stage of diffusion but may contribute 
importantly to the predicted proportional change across all ages. 
For ages 35-69, the predicted proportional changes reveal decreases in the logged 
total mortality ratio for nations at early stages of diffusion and increases for nations at 
late stages – the opposite of past trends.  For nations at early stages, the female 
advantage in the logged smoking mortality ratio fell less from 1975-2000 than for 
nations at later stages because female cigarette use had not advanced as far.  Based on 
more recent changes in smoking prevalence, however, nations at earlier stages will 
experience greater future declines in the female advantage in smoking mortality than 
nations at later stages.  Portugal, Spain, Greece, and Japan thus show rising female 
mortality relative to male mortality and a decline in the female advantage.  For nations 
at the later stages, where the smoking prevalence of men and women has reached near 
equality, relative rates of smoking mortality contribute less to future trends in mortality 
than relative rates of non-smoking mortality, which continue to rise.  The United States, 
the United Kingdom, and Ireland thus show declining female mortality relative to male Pampel: Forecasting sex differences in mortality in high income nations  
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mortality and a growing female advantage.  As a summary of these patterns, the 
correlations of the predicted proportional change with the diffusion measure equal .682 
and .590 and indicate greater growth or smaller declines in the female advantage for 




Table 5:  Predicted Proportional Change in Logged Total Mortality Ratio  
  from 2000 to 2020, by Nation and Cigarette Diffusion Measure
 a 
 
  Cigarette  Ages 0-34  Ages 35-69  Ages 70+  All Ages  
 Diffusion  Fixed  Effects Fixed  Effects Fixed  Effects Fixed  Effects 
Nation Measure  No  Yes  No Yes  No  Yes No  Yes 
Spain 3.3  .088  .078  -.120  -.134  -.207  -.141  -.018  -.045 
Portugal 3.4  .088  .083  -.046  -.004  -.065  .036  .026  .053 
Greece 3.4  .088  .099  -.261  -.432  -.301  -.621  -.116  -.230 
Japan 3.6  .088  .104  -.096  -.136  -.248  -.149  -.022  -.051 
Switz. 3.7  .088  .082  .067  .008  -.165  -.053  .093  .038 
Italy 3.8  .088  .083  -.050  -.084  -.188  -.070  .025  .005 
Germany  3.8  .088  .089  .026 -.021 -.189 -.057  .069  .028 
Belgium 3.9  .088  .087  -.132  -.240  -.274  -.260  -.014  -.094 
Australia 4.1 .088  .087  .076  .017  -.180  -.020  .112  .057 
France  4.2  .088  .081  .052 -.006 -.171 -.054  .079  .026 
NZ  4.2  .088  .088  .191 .193 -.082 .084  .187  .152 
Austria  4.3  .088  .079  .000 -.032 -.195 -.050  .054  .026 
Nether.  4.3  .088  .117  .139 -.021 -.148 -.166  .144  .008 
Sweden 4.3  .088  .096  .077  .041  .097  .010  .106  .073 
Denmark 4.6 .088  .086  .048  .028  -.150  -.023  .081  .058 
Canada  4.6  .088  .088  .166 .106 -.152 .018  .171  .101 
Finland 4.8  .088  .074  -.006  -.092  -.127  -.034  .071  .000 
Ireland  4.9  .088  .100  .142 .084 -.128 .054  .150  .103 
Norway  5.4  .088  .084  .008 -.008 -.154 -.038  .060  .039 
US  5.4  .088  .086  .164 .121 -.138 .053  .164  .110 
UK  6.1  .088  .100  .236 .161 -.077 .081  .204  .140 
r with                   
  Diffusion 1.000 .000  .104  .682 .590 .499 .507 .686 .596 
 
a Based on assumed falling rate of increase (or decrease at ages 70+) 
 
                                                        
17 The fixed effects models project smaller increases than the other model, but the relative position of nations remains similar in both projections.   Demographic Research: Volume 13, Article 18 
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Stated differently, these results reveal that the past changes in logged mortality 
ratios are correlated negatively with the predicted future changes across nations 
(r = -.62).  Those nations at the later stages of the cigarette epidemic and having 
recently experienced the largest decline in the logged ratio or female advantage likely 
will in turn experience the largest predicted rise in the near future; those nations at the 
earlier stages of the cigarette epidemic and having recently experienced the largest 
increase in the logged ratio or female advantage likely will in turn experience the 
largest predicted decline in the near future.   
For ages 70 and over, both the predicted logged smoking and non-smoking ratios 
typically lead to a declining female advantage, and the predicted proportional change 
for most nations in Table 5 is negative.  However, the degree of change again correlates 
with cigarette diffusion (r = .499 and .507).  The decline in the female advantage is 
greater for nations at the earlier stage of diffusion that have recently experienced rising 
rates of female smoking prevalence than for nations at the later stages of diffusion that 
now have similar rates of male and female smoking prevalence.  The main difference 
between the older ages and younger ages stems from the logged non-smoking mortality 
ratio, which has fallen at the older ages rather than increased.   
For all ages combined, the growing female advantage at younger ages outweighs 
the declining female advantage at older ages to produce largely positive values for the 
predicted proportional changes.  Based on the models, all but four nations – Spain, 
Greece, Japan, and Belgium – can expect the female advantage in mortality to continue 
rising.  The continued rise again proves larger for nations at later stages of cigarette 
diffusion than earlier stages.  The United Kingdom and the United States, for example, 
would appear to experience substantial increases in the female advantage, reaching 
values ranging from 11.0 to 20.4 percent.  These nations have already experienced the 
consequences of rising female smoking for the sex differential.  With smoking 
prevalence having reached near equality, non-smoking mortality contributes more to the 
sex differential, and, based on past trends, would contribute to a growing differential 
overall.   
To illustrate these national differences, Figure 4 graphs the predicted logged total 
mortality ratio for two nations – Spain (early stage) and the United Kingdom (late 
stage) – at different stages of cigarette diffusion.  With the female advantage declining 
in future decades in Spain and rising in future decades in the United Kingdom, the 
directions of change contrast starkly.  Perhaps more importantly, projections based on 
the simple continuation of past trends within each nation – without attending to 
smoking-attributed mortality and smoking trends – fail to capture the likely reversal of 
the differential in the future.   
The predicted proportional changes shown in Table 5 differ when based on 
alternate assumptions about the trajectory of the logged non-smoking mortality ratio.  If Pampel: Forecasting sex differences in mortality in high income nations  
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the models assume that in the future the logged non-smoking mortality ratio remains 
unchanged from current levels or reverses course to decline, the projections reveal 
larger negative changes in the logged total mortality ratio for nations at earlier stages of 
diffusion and smaller growth for nations at later stages of diffusion.  However, the 
relative position of the nations changes little.  The influence of the logged smoking 
mortality ratio and the recent trends in smoking prevalence will produce national 
differences in the future logged ratios that continue to vary with cigarette diffusion. 
 
 
Figure 4:  Predicted Trends (Fixed Effects OLS Regression Model) in Logged  
  Total Mortality Ratio from 1975-2020, by Nation and Stage of  
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6. Discussion  
After widening for nearly 100 years, sex differences in mortality have over the last 
decade or two begun to narrow in many high income Western nations (Trovato and 
Lalu 1996, 1998; Waldron 1993, 2000).  The results presented here for measure of 
logged mortality ratios (see also Pampel 2002) demonstrate that the reversal has a 
specific cause – the growing use of cigarettes by women.  Whereas the female 
advantage shown in the logged ratios for smoking-attributed deaths has declined, it has 
continued to grow for non-smoking deaths (although perhaps not at the same pace today 
as earlier). 
Since current smoking deaths stem from smoking prevalence in previous decades, 
future relative rates of smoking-attributed mortality can be forecast from recent changes 
in cigarette use by men and women.  Such forecasts demonstrate that the equalization of 
smoking-attributed mortality will continue at least until 2020 (the latest forecast date 
given available data and the lag between smoking and smoking death).  However, 
compared to the past, the rate of decline of the logged ratios in smoking mortality 
appears to slow in the future.  As cigarette use among women and men move toward 
parity, smoking-attributed mortality will contribute less to the sex differential for all 
causes.  Many nations have already reached this point, and, absent a major shift in 
norms and preferences, cigarette use will do little to affect the trajectory of the sex 
differential overall.  If smoking behavior of women relative to men remains near 
equality, then the contribution of smoking-attributed mortality of women relative to 
men will change little.  
Given the declining contribution of smoking mortality to the relative mortality 
rates overall, the contribution of trends in non-smoking mortality becomes critical.   
Having risen steadily over the past two to three decades, the sex differential in non-
smoking mortality will likely continue to rise in the near future, perhaps at a slower 
rate.  If so, the sex differential for all causes will, on average, also rise.  This prediction 
depends on the assumed continuation of increases in the female advantage in causes of 
death unrelated to smoking, and past patterns obviously do not guarantee the same in 
the future.  If instead, the past growth in the female advantage in non-smoking mortality 
is assumed to immediately cease or even reverse direction, it would lead to different 
predictions:  The total sex differential would show no growth or decline.   
Will relative trends in male and female non-smoking mortality change in the 
future?  On one hand, a reversal in past growth of the female advantage as yet seems 
unlikely.  Despite movement toward equality in other areas of social life, norms of male 
and female health behavior remain sufficiently distinct to continue favoring women.  
Moreover, female longevity (at least among non-smokers) has not yet come close to a 
ceiling that would slow future growth, allow male longevity to catch up, and reduce the Pampel: Forecasting sex differences in mortality in high income nations  
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sex differential.  As a result, deaths from suicide, homicide, accidental injury, cancer, 
COPD, stroke, and heart disease that have little direct relationship to smoking do not 
indicate convergence between men and women.  On the other hand, reductions in the 
use of tobacco by men may reflect a broader and growing concern with good health that 
may soon bring rewards in other areas of health.  Such trends may narrow the gap in 
non-smoking mortality between men and women. 
Whatever the future trend on average, nations will likely continue to demonstrate 
considerable diversity in the patterns of change in relative male and female rates of 
smoking and non-smoking mortality.  The diversity in smoking mortality relates closely 
to the stage of cigarette diffusion.  A simple measure of the historical timing of the 
spread of cigarette use relates closely enough to sex differences in smoking prevalence 
to help account for differences across nations in observed sex differences in smoking 
mortality.  Given this relationship, the forecasts reveal that nations at earlier stages of 
the epidemic will experience the most harm to female mortality from smoking, and that 
nations at later stages will have already experienced most of the harm.  With smoking 
contributing more to the sex differential in mortality overall in nations at earlier stages, 
it will in the future slow the growth in the female advantage that occurred in the past.  
With smoking contributing less to the sex differential in mortality overall in nations at 
later stages of diffusion, it can be expected to grow more than it has in the past.  In 
rough terms, nations of northern Europe and the former English colonies that 
experienced the smoking epidemic first will likely have the largest increase in the sex 
differential.  Nations in southern Europe that experienced the smoking epidemic last 
will have the smallest increase or even a short-term decrease.   
These findings may depend on the particular measure of sex differences used in 
the analysis.  The reliance on smoking and non-smoking mortality rates with a floor of 
zero and considerable skew at the other end of the distribution warrants the use of 
relative measures.  Logged mortality ratios focus on relative mortality rates of men and 
women, reduce the skew in the measures, and are invariant to choice of numerator and 
denominator.  However, focusing on absolute differences in life expectancies might 
change the results.  Future research needs to investigate this possibility and translate 
mortality rates into life table functions. 
The findings also depend on the quality of the data on smoking and non-smoking 
mortality and the ability to separate the two types of causes.  The indirect estimation 
technique based on excess lung cancer has many advantages but nonetheless has been 
subject to criticisms, and other estimation techniques might produce different results.  
The measures of smoking prevalence and cigarette consumption, important 
determinants of smoking mortality that drive the forecasts, lack comparability across 
nations and may weaken the predictive power of the models.  The measures relate 
clearly to smoking-related mortality and help improve the forecasts, but better measures Demographic Research: Volume 13, Article 18 
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of smoking behavior, were they available, would do more to increase confidence in the 
models and findings.  Another obvious weakness of the analysis comes from the need to 
simply project alternative trajectories in the sex differential in non-smoking mortality 
without any theoretically grounded determinants.  Still, use of these measures to 
forecast future mortality improves on forecasts based only on recent trends and offers 
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Appendix 
To summarize the more specific details of the indirect standardization approach to 
computing smoking-attributed deaths, Sterling, Rosenbaum, and Weinkam (1993) list 
four steps.  First, the method computes excess lung cancer deaths for each age group 
(from 35-39 to 75-79) and sex (males and females) as the difference between actual 
lung cancer deaths and lung cancer deaths expected from the rates among a non-
smoking population.
18  Although deaths from tobacco also occur before age 35, the 
small number makes reliable estimation difficult.   
Second, the method estimates the proportion of current smokers in each age and 
sex group by assuming that the observed lung cancer mortality rate results from a 
mixture of such deaths among never smokers and current smokers.  The assumption 
implies that the total lung cancer death rate for any age and sex group equals the 
weighted sum of the rates of current smokers and never smokers, with the weights equal 
to the proportion of smokers and non-smokers.  The lung cancer death rates for current 
smokers and never smokers obtained from step one make it possible to solve for the 
unknown proportion of smokers.    
Third, the method calculates excess risk by cause of death (other than lung cancer) 
for each age and sex group from two pieces of information: the proportion current 
smokers obtained in step two, and the relative risk of current versus never smokers for 
each cause of death.  The categories for cause of death include upper aero-digestive 
cancer, other cancer, COPD, other respiratory diseases, vascular diseases, and other 
medical diseases.  The relative risks come from the American Cancer Society’s 
prospective Cancer Prevention Study II of one million Americans ages 30 and older 
from 1982-1992.  The large sample allows reliable estimation of the mortality of current 
smokers and never smokers by age, sex, and cause of death.  The excess risk then 
equals the proportion smokers times the relative risk (minus one) for each cause.   
However, some of the excess risk associated with smoking stems from confounding 
with other risk factors such as drinking, poverty, poor diet, hazardous occupations, and 
lack of exercise.  To compensate for the problem of confounding, Peto et al. halve these 
estimates of excess risk for causes other than lung cancer.
19 
Fourth, based on total deaths and the proportion of deaths attributed to smoking by 
the excess risk and proportion smokers, the method calculates the actual number of 
                                                        
18 Peto et al. (1994:A.50) state: “Because lung cancer rates are particularly unreliable in extreme old age, the proportions of each disease category 
attributed to smoking will simply be taken to be the same at 80+ as at 75-79.” 
19 The method does not halve the number of smoking-attributed deaths, but halves the excess risk for causes other than lung cancer.  Peto et al. 
(1994:A.49) note that halving does not greatly reduce the proportion of smoking-attributed deaths where smoking and lung cancer are common: 
“For example, whether the excess is 400% or 800%, the large majority (either 4/5 or 8/9, in this example) of all such deaths will still be attributed 
to tobacco. But where only a minority of deaths are attributable to tobacco, halving the percentage excess will almost halve the number attributed 
to tobacco.” Pampel: Forecasting sex differences in mortality in high income nations  
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smoking-attributed deaths for each cause, age group, and sex.  Total deaths by age, sex, 
and cause come from the World Health Organization (1996).  Summing over the causes 
provides total numbers of smoking-attributed and other deaths, and population figures 
allow calculation of rates.   
Debate exists over the accuracy of the indirect estimates, with critics arguing that 
they overstate deaths due to tobacco in two ways (Sterling, Rosenbaum, and Weinkam 
1993).  One, the relative risks of cause-specific deaths for smokers and non-smokers 
come from the Cancer Prevention Study II, a nonrandom sample of the U.S. population.  
Over-representing affluent and highly educated volunteers, the study tends to understate 
deaths among never smokers.  Two, the method does not directly adjust with statistical 
controls for confounding by other harmful statuses and behaviors associated with both 
smoking and death, and therefore overstates the harm of cigarette use.
20 
To counter concerns about the possible overstatement of smoking-attributed 
mortality, Peto et al. halve their initial estimates of excess smoking risk for causes other 
than lung cancer.  Although in some ways arbitrary and made intentionally large to 
conservatively estimate smoking-attributed mortality, the adjustment gives nearly the 
same number of smoking deaths as the U.S. Surgeon General (DHHS 1989) does when 
combining national mortality rates in the U.S. with additional data on the prevalence of 
smoking (Peto et al. 1992).  Other tests of validity similarly support the indirect 
method.  Brønnum-Hansen and Juel (2000) find with Danish data that the indirect 
method gives results nearly identical to a method that uses retrospective information on 
smoking.
21  Valkonen and van Poppel (1997:308) find with data on the Nordic nations 
and the Netherlands that the Peto et al. method shows “a relatively close 
correspondence . . . [with results] obtained in prospective national studies.”  Othe rs  
suggest that the method may in fact understate rather than, as argued by critics, 
overstate tobacco-attributed mortality. The use of CPS-II overstates smoking-attributed 
mortality by 19 percent, and confounding factors overstate smoking-attributed mortality 
by 2.5 percent (Malarcher et al. 2000; Thun, Apicella, and Henley 2000).  Given these 
findings, the 50 percent adjustment in excess risk made by Peto et al. errs on the side of 
caution in identifying the harm of smoking. 
                                                        
20 Another criticism suggests that the estimates of the relative risks of current smokers compared to never smokers ignore former smokers and 
differences among current smokers in the intensity of cigarette use.  Although the method simplifies procedures by dividing the population into 
current and never smokers, the use of excess lung cancer deaths to estimate smoking prevalence also accounts for deaths among former smokers 
(Valkonen and van Poppel (1997:308).  By using lung cancer rates to reflect the smoking history of a group in terms of prevalence, duration, and 
intensity, the procedure allows for comparisons of nations that differ in the proportion of smokers and former smokers, and the mix of heavy, 
moderate, and light smokers among current and former users. Although not measured directly, the exposure to cigarette use of all types shows in 
the indirect estimates. 
21 Specifically, their estimate of the proportion of deaths from selected causes in 1993 that are attributable to cigarette smoking equals 33 percent 
for men, which differs little from the estimate of 35 percent for the Peto et al. method.  For women, the two estimates of 23 and 25 percent again 
reveal little difference. 